Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
12/09/2025
The Taiwan dollar rose 0.3% against the US dollar to 30.252.
Latest
2 m ago
Midday review: Shanghai Composite Index rose slightly by 0.24% in the morning, with the non-ferrous metals and gold sectors all experiencing significant gains.
4 m ago
Sodium ion battery sector hits bottom and rises, Mengguli soars more than 10%
5 m ago
Hong Kong stock market anomaly | Keen Smart-W (02590.HK) rose nearly 7% in early trading, the company has recently deepened global cooperation, and institutions believe it has great potential performance elasticity.
5 m ago
SenDau Intelligent's trading volume reached 10 billion yuan, but is now down by 5.95%.
6 m ago
After a sharp decline yesterday, today Hong Kong stocks in the innovative pharmaceutical concept sector rebounded across the board. As of the time of publication, Konruns Pharmaceuticals-B rose more than 14%, Huang Pharmaceutical rose more than 6%, Rundong Pharmaceuticals, Liputan Biological-B rose more than 5%, and Geco-B rose more than 4%. On the news front, many pharmaceutical companies responded, stating that they are aware of market rumors that the United States may limit innovative drugs from China, but believe that these rumors currently do not affect the expectations for Chinese innovative drugs to go global. Market participants believe that leading biotech companies such as BeiJing ShenZhou and Xinda Pharmaceuticals are expected to maintain a high growth trend after achieving a profit turning point in 2025. With the improvement of industrialization capabilities and expansion of product lines, it is expected that more biotech companies will enter the profit cycle in the future. (First Financial News)
See all latest
